New Mexico Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Health Reporter.

Press releases published on June 15, 2026

Jun. 15, 2026

ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)

Indeterminate GlobeNewswire

Jun. 15, 2026

Cannabix Technologies Announces Deployment of Marijuana Breath Test (MBT) with Major Industrial Operator in Quebec

Indeterminate GlobeNewswire

Jun. 15, 2026

Fate Therapeutics Appoints Laura Hamill to Board of Directors

Indeterminate GlobeNewswire

Jun. 15, 2026

Sienna Announces June Dividend

Indeterminate GlobeNewswire

Jun. 15, 2026

Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026

Indeterminate GlobeNewswire

Jun. 15, 2026

Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing

Indeterminate GlobeNewswire

Jun. 15, 2026

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

Indeterminate GlobeNewswire

Jun. 15, 2026

Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway

Indeterminate GlobeNewswire

Jun. 15, 2026

AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency

Indeterminate GlobeNewswire

Jun. 15, 2026

SpyGlass Pharma Appoints Shannon Treviño as General Counsel

Indeterminate GlobeNewswire

Jun. 15, 2026

Porosome Therapeutics Announces Global Drug Development Partnership with the Largest Governmental R&D Organization in India

Indeterminate GlobeNewswire

Jun. 15, 2026

Spyre Announces Potential Best-in-Class SPY002 (anti-TL1A) Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients

Indeterminate GlobeNewswire

Jun. 15, 2026

Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2026 EHA Congress in Oral Presentation

Indeterminate GlobeNewswire

Jun. 15, 2026

Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption

Indeterminate GlobeNewswire

Jun. 15, 2026

Pasithea Therapeutics Announces Exhibit at Children’s Tumor Foundation 2026 NF Conference

Indeterminate GlobeNewswire

Jun. 15, 2026

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign

Indeterminate GlobeNewswire

Jun. 15, 2026

Axsome Therapeutics Presents New Data Highlighting its Innovative Sleep Medicine Portfolio at SLEEP 2026

Indeterminate GlobeNewswire

Jun. 15, 2026

Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman

Indeterminate GlobeNewswire

Jun. 15, 2026

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire

Jun. 15, 2026

Bio Usawa Appoints Dr. Aida Habtezion, Former Chief Medical Officer at Pfizer, to its Board of Directors

Indeterminate GlobeNewswire